Allergan Inc reported better-than-expected first-quarter profit on strong sales of Botox and other products and said it was reviewing an unsolicited $47 billion takeover bid from Valeant Pharmaceuticals International Inc.In reporting its quarterly results on Wednesday, Allergan noted it has in place a one-year stockholder rights plan, commonly called a poison pill, meant to give the company more time to weigh the offer.Excluding special items, Allergan earned $1.18 per share, well above the average analysts' forecast of $1.13 per share compiled by to Thomson Reuters I/B/E/S.The company also raised its full year profit forecast, excluding special items, to between $5.64 and $5.73 per share. In February, it had predicted $5.36 to $5.48 per share.
Allergan, Inc. is a multi-specialty health care Company focused on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter products. Shares of AGN fell by 0.67% or $-1.11/share to $165.21. In the past year, the shares have traded as low as $81.33 and as high as $170.05. On average, 3976360 shares of AGN exchange hands on a given day and today's volume is recorded at 1117035.
Thomson Reuters Corporation (Thomson Reuters), is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.17% or $0.06/share to $35.42. In the past year, the shares have traded as low as $31.38 and as high as $38.73. On average, 869666 shares of TRI exchange hands on a given day and today's volume is recorded at 359532.
Thomson Reuters Corporation (Thomson Reuters), is a provider of information for the world?s businesses and professionals. Shares of TRI traded higher by 0.34% or $0.13/share to $38.59. In the past year, the shares have traded as low as $33.08 and as high as $42.10. On average, 929705 shares of TRI.TO exchange hands on a given day and today's volume is recorded at 383060.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 1.15% or $-1.54/share to $131.81. In the past year, the shares have traded as low as $72.25 and as high as $153.10. On average, 2631170 shares of VRX exchange hands on a given day and today's volume is recorded at 1274478.
Valeant Pharmaceuticals International, Inc., formerly Biovail Corporation, is a multinational, specialty pharmaceutical company that develops, manufactures and markets a range of pharmaceutical products. Shares of VRX fell by 1.04% or $-1.51/share to $143.57. In the past year, the shares have traded as low as $72.59 and as high as $170.45. On average, 390633 shares of VRX.TO exchange hands on a given day and today's volume is recorded at 115743.
Source
